Cargando…
Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
Protocadherin10 (PCDH10), a member of the nonclustered protocadherin family, functions as a tumor suppressor in many cancers. The aim of this study was to evaluate the expression level and prognostic value of PCDH10 in hepatocellular carcinoma (HCC) patients. Quantitative real-time polymerase chain...
Autores principales: | Bing, Yuntao, Tian, Maolin, Li, Gang, Jiang, Bin, Ma, Zhaolai, Li, Lei, Wang, Liang, Wang, Hangyan, Xiu, Dianrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392931/ https://www.ncbi.nlm.nih.gov/pubmed/30170418 http://dx.doi.org/10.1097/MD.0000000000012055 |
Ejemplares similares
-
circEPS15 Overexpression in Hepatocellular Carcinoma Modulates Tumor Invasion and Migration
por: Jiang, Bin, et al.
Publicado: (2022) -
Abdominal apoplexy because of the rupture of gastroduodenal artery and inferior pancreaticoduodenal artery: A case report
por: Wang, Hangyan, et al.
Publicado: (2017) -
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Curia, Maria Cristina, et al.
Publicado: (2019) -
The pancreatic juice length in the stent tube as the predicting factor of clinical relevant postoperative pancreatic fistula after pancreaticoduodenectomy
por: Wang, Hangyan, et al.
Publicado: (2017) -
Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016)